‘Highly concerning’: Major medical groups react to Trump’s claim that Tylenol is linked to autism
Medical organizations and scientific groups are responding to the recent claims made by the Trump administration regarding the use of acetaminophen during pregnancy and its potential link to autism. Despite limited evidence supporting this association, President Trump announced during a White House press conference that the FDA would be recommending that women limit the use of Tylenol unless medically necessary.
However, major medical organizations like the American College of Obstetricians and Gynecologists (ACOG) strongly rejected this claim, stating that over 20 years of research have shown no direct link between acetaminophen use during pregnancy and autism. They emphasized the importance of acetaminophen in managing pain and fever in pregnant women, highlighting the risks associated with leaving these conditions untreated.
Similarly, the Society for Maternal-Fetal Medicine (SMFM) reaffirmed that acetaminophen is a safe medication for pregnant women and emphasized the risks of untreated fever and pain during pregnancy. They stated that acetaminophen is essential for managing these conditions and ensuring the health of both the pregnant person and the fetus.
In response to claims made about vaccines potentially causing autism, medical groups like the American Academy of Pediatrics (AAP) denounced these statements as dangerous and misleading. They emphasized that numerous studies have found no credible link between childhood vaccines and autism, stressing the importance of vaccination in protecting children from serious diseases.
The Trump administration also announced the approval process for a drug called leucovorin as a possible treatment for autism, despite limited evidence supporting its efficacy. The Coalition of Autism Scientists cautioned against recommending leucovorin as a treatment, citing methodological weaknesses in existing studies and the need for more rigorous research.
The Autism Society of America (ASA) condemned the promotion of unfounded claims about causes and treatments for autism, emphasizing the complexity of the condition and the need for evidence-based research. They called for increased investment in high-quality autism research and warned against premature claims that could create false hope and harm within the autism community.
Overall, medical organizations are urging caution and emphasizing the importance of evidence-based research in addressing complex issues like autism and the use of medications during pregnancy. It is crucial to rely on scientific evidence and expert recommendations to ensure the safety and well-being of individuals affected by these conditions.



